416 related articles for article (PubMed ID: 19926696)
1. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores.
Hippisley-Cox J; Coupland C
BMJ; 2009 Nov; 339():b4229. PubMed ID: 19926696
[TBL] [Abstract][Full Text] [Related]
2. Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2012 May; 344():e3427. PubMed ID: 22619194
[TBL] [Abstract][Full Text] [Related]
3. Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores.
Collins GS; Mallett S; Altman DG
BMJ; 2011 Jun; 342():d3651. PubMed ID: 21697214
[TBL] [Abstract][Full Text] [Related]
4. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore.
Hippisley-Cox J; Coupland C; Robson J; Sheikh A; Brindle P
BMJ; 2009 Mar; 338():b880. PubMed ID: 19297312
[TBL] [Abstract][Full Text] [Related]
5. Predicting the risk of chronic Kidney Disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores.
Hippisley-Cox J; Coupland C
BMC Fam Pract; 2010 Jun; 11():49. PubMed ID: 20565929
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232
[No Abstract] [Full Text] [Related]
7. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
Hippisley-Cox J; Coupland C; Brindle P
BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
[No Abstract] [Full Text] [Related]
8. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.
Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Minhas R; Sheikh A; Brindle P
BMJ; 2008 Jun; 336(7659):1475-82. PubMed ID: 18573856
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2011 Aug; 343():d4656. PubMed ID: 21846713
[TBL] [Abstract][Full Text] [Related]
10. Effect of competing mortality risks on predictive performance of the QFracture risk prediction tool for major osteoporotic fracture and hip fracture: external validation cohort study in a UK primary care population.
Livingstone SJ; Morales DR; McMinn M; Eke C; Donnan P; Guthrie B
BMJ Med; 2022; 1(1):e000316. PubMed ID: 36936595
[TBL] [Abstract][Full Text] [Related]
11. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study.
Hippisley-Cox J; Coupland C; Brindle P
BMJ; 2013 May; 346():f2573. PubMed ID: 23641033
[TBL] [Abstract][Full Text] [Related]
12. External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort study.
Dagan N; Cohen-Stavi C; Leventer-Roberts M; Balicer RD
BMJ; 2017 Jan; 356():i6755. PubMed ID: 28104610
[TBL] [Abstract][Full Text] [Related]
13. Derivation and validation of the CFracture competing risk fracture prediction tool compared with QFracture in older people and people with comorbidity: a population cohort study.
Livingstone SJ; Guthrie B; McMinn M; Eke C; Donnan PT; Morales DR
Lancet Healthy Longev; 2023 Jan; 4(1):e43-e53. PubMed ID: 36610448
[TBL] [Abstract][Full Text] [Related]
14. Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density.
Klop C; de Vries F; Bijlsma JW; Leufkens HG; Welsing PM
Ann Rheum Dis; 2016 Dec; 75(12):2095-2100. PubMed ID: 26984006
[TBL] [Abstract][Full Text] [Related]
15. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].
Lippuner K
Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study.
Hippisley-Cox J; Coupland C
BMJ Open; 2015 Mar; 5(3):e007825. PubMed ID: 25783428
[TBL] [Abstract][Full Text] [Related]
17. Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fractures.
Weycker D; Edelsberg J; Barron R; Atwood M; Oster G; Crittenden DB; Grauer A
Osteoporos Int; 2017 Sep; 28(9):2565-2571. PubMed ID: 28593447
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of QMortality risk prediction algorithm to estimate short term risk of death and assess frailty: cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2017 Sep; 358():j4208. PubMed ID: 28931509
[No Abstract] [Full Text] [Related]
19. Assessing Risk of Osteoporotic Fractures in Primary Care: Development and Validation of the FRA-HS Algorithm.
Francesco L; Elisa B; Raffaella M; Alessandro P; Iacopo C; Giampiero M; Bruno F; Daniel PA; Luisa BM; Claudio C
Calcif Tissue Int; 2017 Jun; 100(6):537-549. PubMed ID: 28160026
[TBL] [Abstract][Full Text] [Related]
20. Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway.
Hoff M; Meyer HE; Skurtveit S; Langhammer A; Søgaard AJ; Syversen U; Dhainaut A; Skovlund E; Abrahamsen B; Schei B
Osteoporos Int; 2017 Oct; 28(10):2935-2944. PubMed ID: 28668994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
